PACB EBITDA Margin
Pacific Biosciences Of California · EBITDA Margin
PACB EBITDA Margin
Latest reported-68.49%period ending
PACB TTM EBITDA Margin (-8491.21% → -68.49%)
TTM ebitda margin
High-resolution chart · PNG
PACB ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -68.4858% | |
| -66.6131% | |
| -95.432% | |
| -66.3219% | |
| -71.8282% | |
| -152.3028% | |
| -157.6298% | |
| -188.6438% | |
| -187.4692% | |
| -129.7215% | |
| -138.2808% | |
| -168.4468% | |
| -195.7109% | |
| -215.0182% | |
| -219.8567% | |
| -194.893% | |
| -193.4867% | |
| -179.244% | |
| -192.305% | |
| -92.9935% | |
| -59.0125% | |
| -52.2743% | |
| 49.4011% | |
| -44.1891% | |
| -48.1314% | |
| -44.8903% | |
| -78.7482% | |
| -124.947% | |
| -126.7223% | |
| -129.9766% | |
| -118.1848% | |
| -98.6018% | |
| -89.2999% | |
| -93.7758% | |
| -86.4745% | |
| -84.4899% | |
| -79.0114% | |
| -72.6265% | |
| -74.5464% | |
| -49.9294% | |
| -60.4761% | |
| -50.7055% | |
| -52.2731% | |
| -89.1016% | |
| -66.454% | |
| -90.1377% | |
| -96.7637% | |
| -108.3655% | |
| -172.6919% | |
| -203.84% | |
| -255.1187% | |
| -306.4674% | |
| -388.3925% | |
| -375.7236% | |
| -337.2744% | |
| -272.6044% | |
| -237.6477% | |
| -220.7948% | |
| -306.9811% | |
| -543.3568% | |
| -1,132.9825% | |
| -9,960.6862% | |
| -8,068.9367% | |
| -8,251.6024% | |
| -8,491.2147% |